CXCR4 has been shown to co-localize with CRC stem cell markers, such as Lgr5, CD133, and CD44, which are thought to be associated with the epithelial-mesenchymal transition process and resistance to cancer drug therapy [Figure 6][42]. The gene discussed is PROM1; the disease is colorectal carcinoma.